Company Analysis The Ensign Group, Inc.
1. Summary
Advantages
- The stock's return over the last year (13.45%) is higher than the sector average (-31.05%).
- Current debt level 5.55% is below 100% and has decreased over 5 years from 15.79%.
- The company's current efficiency (ROE=14.04%) is higher than the sector average (ROE=9.61%)
Disadvantages
- Price (130.95 $) is higher than fair price (47.73 $)
- Dividends (0.1813%) are below the sector average (0.5473%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| The Ensign Group, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.1% | -22.6% | 2.3% |
| 90 days | -11.3% | -35.5% | 6.3% |
| 1 year | 13.5% | -31% | 31.5% |
ENSG vs Sector: The Ensign Group, Inc. has outperformed the "Healthcare" sector by 44.5% over the past year.
ENSG vs Market: The Ensign Group, Inc. has significantly underperformed the market by -18.06% over the past year.
Stable price: ENSG is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ENSG with weekly volatility of 0.2587% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (130.95 $) is higher than the fair price (47.73 $).
Price is higher than fair: The current price (130.95 $) is 63.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (31.02) is lower than that of the sector as a whole (48.72).
P/E vs Market: The company's P/E (31.02) is lower than that of the market as a whole (49.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.34) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (4.34) is higher than that of the market as a whole (3.18).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.74) is lower than that of the sector as a whole (33.75).
P/S vs Market: The company's P/S indicator (1.74) is lower than that of the market as a whole (10.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (22.24) is higher than that of the sector as a whole (-22.17).
EV/Ebitda vs Market: The company's EV/Ebitda (22.24) is lower than that of the market as a whole (28.35).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.57% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.57%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (123.79%).
5.4. ROE
ROE vs Sector: The company's ROE (14.04%) is higher than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (14.04%) is higher than that of the market as a whole (10.67%).
5.5. ROA
ROA vs Sector: The company's ROA (5.01%) is higher than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (5.01%) is lower than that of the market as a whole (6.44%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (8.93%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (8.93%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.1813% is below the average for the sector '0.5473%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.1813% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 0.1813% has been growing over the last 5 years. Growth over 5 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (6.16%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 15.11.2024 | Shaw Daren Director |
Purchase | 144.25 | 126 219 | 875 |
| 13.09.2024 | Abbott Swati Bargotra Director |
Sale | 152.45 | 152 450 | 1 000 |
| 15.07.2024 | Burton Spencer President and COO |
Sale | 136.19 | 422 053 | 3 099 |
| 15.07.2024 | Burton Spencer President and COO |
Purchase | 21.39 | 66 288 | 3 099 |
| 12.07.2024 | Burton Spencer President and COO |
Sale | 135.04 | 1 015 370 | 7 519 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
